Computational drug design by inhivePublished: January 15, 2019
Last year, we extended our advisory portfolio to address the scientific needs of our clients, in order to provide immediate value to their R&D labs. Today, we are excited to announce that we have once again been selected for an engagement with a research-driven pharmaceutical client to provide computational drug design services. "This will cover the full spectra of methods in this space, ranging from quantum mechanics to large macromolecular simulations.", says Dr. Leonard Henkes, Senior Advisor for Computational Chemistry at inhive, "We will assess receptor-ligand interactions and identify the next hit.". This is an important factor in speeding up drug development efforts; to ultimately deliver better medicines to patients.
Best wishes for 2019!Published: December 22, 2018
The inhive group Germany wishes all of your customers, families and friends relaxing Christmas holidays and a happy new year 2019!
data2day – Data Science SymposiumPublished: October 1, 2018
inhive joined the exciting data science conference in the Rhein-Main-Neckar Area data2day at the Print Media Academy in Heidelberg. This 2-day event was bridging the gap from classical approaches on data warehouses and business intelligence to modern big data and machine learning solutions. Stakeholders from various industries were present and discussing current techniques and challenges.